Axonis Therapeutics logo

Axonis Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$115M


Axonis Therapeutics is a biotechnology company developing novel neuromedicines targeting neurological disorders like epilepsy and pain.

Total Funding

$115M

Headquarters

Boston, USA

Founded

N/A

Website

Focus Areas

Biotechnology
Neuromedicines
Clinical Development
Neurological Disorders
KCC2-targeting
Therapeutics

Investors